Clinical trial
Clinical Investigation of Transplantation of Neural Stem Cell-derived Neurons for the Treatment of Parkinson's Disease
NCT03309514 is registered in ClinicalTrials.gov with NeuroGeneration as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Investigation of Transplantation of Neural Stem Cell-derived Neurons for the Treatment of Parkinson's Disease
- Lead sponsor
- NeuroGeneration
- Phase
- Phase 1/2
- Overall status
- Withdrawn
- Start date
- June 30, 2022
- Completion date
- June 30, 2024
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
parkinson's disease